Non-invasive measurement of the haemodynamic effects of inhaled salbutamol, intravenous L-arginine and sublingual nitroglycerin

British Journal of Clinical Pharmacology

Volumn 68, Issue 1, 2009, Pages 23-33

  Tahvanainen, Anna ^a   Leskinen, Miia ^a   Koskela, Jenni ^a   Ilveskoski, Erkki ^a   Alanko, Juha ^a   Kähönen, Mika ^b   Kööbi, Tiit ^b   Lehtimäki, Lauri ^b   Moilanen, Eeva ^b   Mustonen, Jukka ^a,c   Pörsti, Ilkka ^a,c  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c SEINÄJOKI CENTRAL HOSPITAL   (Finland)

Author keywords

Endothelium dependent vasorelaxation; Haemodynamics; Nitric oxide; Tilt table test

Indexed keywords

ARGININE; GLYCERYL TRINITRATE; NITRO RESORIBLET; SALBUTAMOL; UNCLASSIFIED DRUG;

ADULT; ARTERY COMPLIANCE; ARTICLE; AUGMENTATION INDEX; BREATH ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HUMAN; IMPEDANCE CARDIOGRAPHY; IMPEDANCE PLETHYSMOGRAPHY; MALE; PRIORITY JOURNAL; PULSE WAVE; RADIAL ARTERY; SUPINE POSITION; SYSTEMIC VASCULAR RESISTANCE; SYSTOLIC BLOOD PRESSURE; TILT TABLE TEST; VASCULAR ENDOTHELIUM; VASODILATATION;

ADULT; ALBUTEROL; ARGININE; BLOOD PRESSURE; CARDIAC OUTPUT; CARDIOGRAPHY, IMPEDANCE; DRUG ADMINISTRATION ROUTES; ENDOTHELIUM, VASCULAR; FEMALE; HEMODYNAMICS; HUMANS; MALE; NITRIC OXIDE; NITROGLYCERIN; SUPINE POSITION; TILT-TABLE TEST; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 67650966712     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2009.03434.x     Document Type: Article

References (52)

1. Feletou M, Vanhoutte PM. Endothelium-derived hyperpolarizing factor: where are we now? Arterioscler Thromb Vasc Biol 2006 26 : 1215 25.
2. Landmesser U, Hornig B, Drexler H. Endothelial function: a critical determinant in atherosclerosis? Circulation 2004 109 (21 Suppl. 1 II27 33.
3. Rumbaut RE, Slaff DW, Burns AR. Microvascular thrombosis models in venules and arterioles in vivo. Microcirculation 2005 12 : 259 74.
4. Rabasseda X. New joint European Hypertension/European Society of Society of Cardiology guidelines for the management of arterial hypertension. Timely Top Med Cardiovasc Dis 2007 11 : E18.
5. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen L, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgozoglu L, Wiklund O, Zampelas A. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007 14 (Suppl. 2 S1 113.
6. Campuzano R, Moya JL, Garcia-Lledo A, Tomas JP, Ruiz S, Megias A, Balaguer J, Asin E. Endothelial dysfunction, intima-media thickness and coronary reserve in relation to risk factors and Framingham score in patients without clinical atherosclerosis. J Hypertens 2006 24 : 1581 8.
7. Madsen PL, Scheuermann Freestone M, Neubauer S, Channon K, Clarke K. Haemoglobin and flow-mediated vasodilation. Clin Sci (Lond) 2006 110 : 467 73.
8. Barac A, Campia U, Panza JA. Methods for evaluating endothelial function in humans. Hypertension 2007 49 : 748 60.
9. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986 315 : 1046 51.
10. Giulia Gagliardi M, Crea F, Polletta B, Bassano C, La Vigna G, Ballerini L, Ragonese P. Coronary microvascular endothelial dysfunction in transplanted children. Eur Heart J 2001 22 : 254 60.
11. Hollenberg SM, Tamburro P, Johnson MR, Burns DE, Spokas D, Costanzo MR, Parrillo JE, Klein LW. Simultaneous intracoronary ultrasound and Doppler flow studies distinguish flow-mediated from receptor-mediated endothelial responses. Catheter Cardiovasc Interv 1999 46 : 282 8.
12. Chen CH, Nevo E, Fetics B, Pak PH, Yin FC, Maughan WL, Kass DA. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation 1997 95 : 1827 36.
13. Hayward CS, Kraidly M, Webb CM, Collins P. Assessment of endothelial function using peripheral waveform analysis: a clinical application. J Am Coll Cardiol 2002 40 : 521 8.
14. McEniery CM, Wallace S, Mackenzie IS, McDonnell B, Yasmin, Newby DE, Cockcroft JR, Wilkinson IB. Endothelial function is associated with pulse pressure, pulse wave velocity, and augmentation index in healthy humans. Hypertension 2006 48 : 602 8.
15. Böger RH, Bode-Böger SM, Mugge A, Kienke S, Brandes R, Dwenger A, Frolich JC. Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis 1995 117 : 273 84.
16. Cooke JP, Andon NA, Girerd XJ, Hirsch AT, Creager MA. Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta. Circulation 1991 83 : 1057 62.
17. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 1992 90 : 1248 53.
18. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet 1991 338 : 1546 50.
19. Bode-Böger SM, Böger RH, Galland A, Tsikas D, Frolich JC. L-arginine-induced vasodilation in healthy humans: pharmacokinetic- pharmacodynamic relationship. Br J Clin Pharmacol 1998 46 : 489 97.
20. Waring WS, Thomson AJ, Adwani SH, Rosseel AJ, Potter JF, Webb DJ, Maxwell SR. Cardiovascular effects of acute oxygen administration in healthy adults. J Cardiovasc Pharmacol 2003 42 : 245 50.
21. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976 16 : 31 41.
22. Wilkinson IB, Hall IR, MacCallum H, Mackenzie IS, McEniery CM, van der Arend BJ, Shu YE, MacKay LS, Webb DJ, Cockcroft JR. Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol 2002 22 : 147 52.
23. Delles C, Schneider MP, Oehmer S, Fleischmann EH, Schmieder RE. L-arginine-induced vasodilation of the renal vasculature is not altered in hypertensive patients with type 2 diabetes. Diabetes Care 2003 26 : 1836 40.
24. Koifman B, Topilski I, Megidish R, Zelmanovich L, Chernihovsky T, Bykhovsy E, Keren G. Effects of losartan + L-arginine on nitric oxide production, endothelial cell function, and hemodynamic variables in patients with heart failure secondary to coronary heart disease. Am J Cardiol 2006 98 : 172 7.
25. McConell GK, Huynh NN, Lee-Young RS, Canny BJ, Wadley GD. L-Arginine infusion increases glucose clearance during prolonged exercise in humans. Am J Physiol Endocrinol Metab 2006 290 : E60 6.
26. Böger RH, Bode-Böger SM. The clinical pharmacology of L-arginine. Annu Rev Pharmacol Toxicol 2001 41 : 79 99.
27. Pretnar-Oblak J, Sabovic M, Sebestjen M, Pogacnik T, Zaletel M. Influence of atorvastatin treatment on L-arginine cerebrovascular reactivity and flow-mediated dilatation in patients with lacunar infarctions. Stroke 2006 37 : 2540 5.
28. Zimmermann C, Haberl RL. L-arginine improves diminished cerebral CO2 reactivity in patients. Stroke 2003 34 : 643 7.
29. Dallinger S, Sieder A, Strametz J, Bayerle-Eder M, Wolzt M, Schmetterer L. Vasodilator effects of L-arginine are stereospecific and augmented by insulin in humans. Am J Physiol Endocrinol Metab 2003 284 : E1106 11.
30. Kööbi T, Kähönen M, Iivainen T, Turjanmaa V. Simultaneous non-invasive assessment of arterial stiffness and haemodynamics - a validation study. Clin Physiol Funct Imaging 2003 23 : 31 6.
31. Kööbi T, Kaukinen S, Ahola T, Turjanmaa VM. Non-invasive measurement of cardiac output: whole-body impedance cardiography in simultaneous comparison with thermodilution and direct oxygen Fick methods. Intensive Care Med 1997 23 : 1132 7.
32. Kööbi T, Kaukinen S, Turjanmaa VM, Uusitalo AJ. Whole-body impedance cardiography in the measurement of cardiac output. Crit Care Med 1997 25 : 779 85.
33. Tsoukias NM, George SC. A two-compartment model of pulmonary nitric oxide exchange dynamics. J Appl Physiol 1998 85 : 653 66.
34. Lehtimäki L, Kankaanranta H, Saarelainen S, Hahtola P, Jarvenpää R, Koivula T, Turjanmaa V, Moilanen E. Extended exhaled NO measurement differentiates between alveolar and bronchial inflammation. Am J Respir Crit Care Med 2001 163 : 1557 61.
35. Lehtonen H, Oksa P, Lehtimäki L, Sepponen A, Nieminen R, Kankaanranta H, Saarelainen S, Jarvenpää R, Uitti J, Moilanen E. Increased alveolar nitric oxide concentration and high levels of leukotriene B(4) and 8-isoprostane in exhaled breath condensate in patients with asbestosis. Thorax 2007 62 : 602 7.
36. Tao J, Liu DH, Wang LC, Wang JM, Wang Y, Yang Z, Lou ZF, Tang AL. Arterial elasticity identified by pulse wave analysis and its relation to endothelial function in patients with coronary artery disease. J Hum Hypertens 2007 21 : 149 53.
37. Egashira K, Hirooka Y, Kuga T, Mohri M, Takeshita A. Effects of L-arginine supplementation on endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary arteriograms. Circulation 1996 94 : 130 4.
38. Hirooka Y, Egashira K, Imaizumi T, Tagawa T, Kai H, Sugimachi M, Takeshita A. Effect of L-arginine on acetylcholine-induced endothelium-dependent vasodilation differs between the coronary and forearm vasculatures in humans. J Am Coll Cardiol 1994 24 : 948 55.
39. Pollock JS, Forstermann U, Mitchell JA, Warner TD, Schmidt HH, Nakane M, Murad F. Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci USA 1991 88 : 10480 4.
40. Bode-Böger SM, Böger RH, Creutzig A, Tsikas D, Gutzki FM, Alexander K, Frolich JC. L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects. Clin Sci (Lond) 1994 87 : 303 10.
41. Morgan DR, Silke B, Dixon LJ, Allen PB, Hanratty CG, McVeigh GE. Central and peripheral haemodynamic effects of L-NAME infusion in healthy volunteers. Eur J Clin Pharmacol 2003 59 : 195 9.
42. Böger RH, Skamira C, Bode-Böger SM, Brabant G, von zur Muhlen A, Frolich JC. Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study. J Clin Invest 1996 98 : 2706 13.
43. Osterziel KJ, Bode-Boger SM, Strohm O, Ellmer AE, Bit-Avragim N, Hanlein D, Ranke MB, Dietz R, Boger RH. Role of nitric oxide in the vasodilator effect of recombinant human growth hormone in patients with dilated cardiomyopathy. Cardiovasc Res 2000 45 : 447 53.
44. Dawes M, Chowienczyk PJ, Ritter JM. Effects of inhibition of the L-arginine/nitric oxide pathway on vasodilation caused by beta-adrenergic agonists in human forearm. Circulation 1997 95 : 2293 7.
45. Xu B, Li J, Gao L, Ferro A. Nitric oxide-dependent vasodilatation of rabbit femoral artery by beta(2)-adrenergic stimulation or cyclic AMP elevation in vivo. Br J Pharmacol 2000 129 : 969 74.
46. Waring WS, Sinclair HM, Webb DJ. Effects of salbutamol and glyceryl trinitrate on large arterial stiffness are similar between patients with hypertension and adults with normal blood pressure. Br J Clin Pharmacol 2006 62 : 621 6.
47. Mason DT, Braunwald E. The effects of nitroglycerin and amyl nitrite on arteriolar and venous tone in the human forearm. Circulation 1965 32 : 755 66.
48. Raviele A, Gasparini G, Di Pede F, Menozzi C, Brignole M, Dinelli M, Alboni P, Piccolo E. Nitroglycerin infusion during upright tilt: a new test for the diagnosis of vasovagal syncope. Am Heart J 1994 127 : 103 11.
49. Girgis RE, Gugnani MK, Abrams J, Mayes MD. Partitioning of alveolar and conducting airway nitric oxide in scleroderma lung disease. Am J Respir Crit Care Med 2002 165 : 1587 91.
50. Delclaux C, Mahut B, Zerah-Lancner F, Delacourt C, Laoud S, Cherqui D, Duvoux C, Mallat A, Harf A. Increased nitric oxide output from alveolar origin during liver cirrhosis versus bronchial source during asthma. Am J Respir Crit Care Med 2002 165 : 332 7.
51. Albillos A, Rossi I, Cacho G, Martinez MV, Millan I, Abreu L, Barrios C, Escartin P. Enhanced endothelium-dependent vasodilation in patients with cirrhosis. Am J Physiol 1995 268 : G459 64.
52. Sumino H, Nakamura T, Kanda T, Sato K, Sakamaki T, Takahashi T, Saito Y, Hoshino J, Kurashina T, Nagai R. Effect of enalapril on exhaled nitric oxide in normotensive and hypertensive subjects. Hypertension 2000 36 : 934 40.